Business Context and Reporting Period
Kura Sushi USA, Inc. filed this Form 8-K under Item 5.02 and Item 8.01. The filing concerns a board appointment rather than financial results. The report date is identified as November 13, 2019, although the filing also references a November 19, 2019 press release and bears a November 19, 2019 signature date.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.
Material Changes
- The Board expanded from four to five directors.
- Kim Ellis was appointed to the Board effective December 1, 2019, serving until the 2020 annual meeting or until her successor is elected and qualified.
- Ms. Ellis was appointed to the Audit Committee and Compensation Committee effective December 1, 2019.
- The Board intended to appoint Ms. Ellis to the planned Strategy and Development Committee, with that committee expected to be formed before the effective date.
Compensation, Outlook, Risks, and Unusual Items
- Ms. Ellis’s annual director compensation includes an $80,000 retainer: $40,000 in cash and $40,000 in stock options for Class A common stock.
- The annual stock-option portion is expected to vest in equal quarterly installments over one year following the grant date.
- As chair of the Strategy and Development Committee, Ms. Ellis will receive an additional $20,000 annual cash retainer.
- She will also receive options to purchase 5,000 shares of Class A common stock, vesting in equal quarterly installments over four years.
- The options are to be granted under the Company’s 2018 Stock Incentive Plan. The filing does not provide an exercise price or valuation.
- The Company and Ms. Ellis will enter into the Company’s standard indemnification agreement.
- The filing states there are no selection arrangements, family relationships, or reportable related-party transactions involving Ms. Ellis.
Important Facts to Verify
- Confirm the effective date of December 1, 2019 and the final committee assignments, including formation of the Strategy and Development Committee.
- Review Exhibit 99.1 for the November 19, 2019 press release and any additional biographical or governance information.
- Verify the grant date, exercise price, share count, and accounting treatment of the stock options.
- Reconcile the filing’s November 13 report date with the November 19 press release and signature dates.